Production Supervisor - Vaccines |
| Req. # 06 ? 023
TITLE: Production Supervisor
LOCATION: Rockville, MD
... |
|
Microbiology Opportunities - Immediate Hire |
| Several of our suburban Maryland biotech and biopharmaceutical clients have IMMEDIATE opportunities ... |
|
Manager, Instrumentation Operations |
| MANAGER, INSTRUMENTATION OPERATIONS
?
Digene, a biomedical industry leader that develops, ... |
|
Safety Associate II |
| Safety Associate II needed for a 6-month renewable contract. This position receives and reviews ... |
|
QA Specialist |
| SeraCare Life Sciences develops, manufactures, and sells a broad range of biological based ... |
|
Product Manager, BS, MS, Ph.D. |
| Product Manager, BS, MS, Ph.D.
Trevigen, Inc. a leader in the development and marketing of ... |
|
Quality Control Analyst |
| VIRxSYS is a private biotechnology company in Gaithersburg, Maryland which develops gene therapy ... |
|
Hospital Sales Consultant (Rockville/Bethesda, MD) |
| Biopharmaceuticals
As a growing subsidiary of an international Fortune 500 company, Berlex is ... |
|
Study Director - Toxicology |
| Client Description: Our client?s enabling drug discovery and development technology allows ... |
|
Biochemistry technicians |
| Calling all Biotechnology professionals!
?
On Assignment Lab Support has multiple opportunities ... |
|
|
Product Safety Monitor
| Details |
Country: USA
Location: MD Gaithersburg
Total applied: 24
Job Type: Employee
Job Status: Full Time
|
|
Product Safety Monitor
A recognized leader in the biotechnology industry, we use the latest advances in science, technology and medicine to develop innovative products that improve the quality of human health.
Management of data for adverse event information received by MedImmune. Utilize medical knowledge to prepare individual case safety reports and periodic reports, obtain follow-up information, and prepare standard and ad hoc reports. Responsible for safety surveillance and assisting in the evaluation of potential safety signals in clinical trial and spontaneous reports in collaboration with Medical Director/Operational Managers. May mentor other Product Safety interns and serve as cross-functional team member as needed. Participate on team projects to accomplish team and department goals and objectives.
Some specific responsibilities of the position are as follows:Reviewing, triaging and processing initial and follow-up adverse event reports for clinical studies and marketed products. Ensuring compliance with worldwide regulatory requirements for safety surveillance. Reporting for post-marketing AEs and liaising with Regulatory regarding SAEs. Assisting in the development of risk management plans and safety reporting criteria for protocols. Evaluating individual SAE reports and aggregate safety data (e.g., search for signals/trends). Assisting in preparation of BLA/NDA and IND safety reports and PSURs, investigator communications, product labeling/package inserts, and other documents as necessary.Active participation in departmental projects, validation exercises, and FDA inspections.
May provide guidance and training to personnel. Bachelor?s and/or advanced degree in a related discipline is preferred. Health professional degree such as RN, BSN, MSN, PA, NP, RPh, PharmD, or other relevant health professional degree required. Requires 1 to 3 years of clinical/post-marketing safety or related experience.Familiarity with clinical trials conduct, experience in medical writing, strong communication skills, and the ability to collaborate and interact with a wide range of health professionals and company personnel. Thorough knowledge and understanding of FDA and EMEA regulations, ICH guidelines, guidelines pertaining to drug safety, cGMPs and cGCPs.
Experience with adverse event software (e.g., ARISg,) and coding dictionaries (e.g., MedDRA) is desirable.
Please send resume, including job code, to: MedImmune, Inc., HR Department, Job Code: 4213-001, One MedImmune Way, Gaithersburg, MD 20878; Fax: 301-398-4215; E-mail: JobOpenings@medimmune.com EOE, M/F/D/V
|
| Related jobs |
|
|
Clinical Research Associate
Seeking a Clinical Research Associate (CRA) for a permanent position in Gaithersburg, MD. Under the direction of the Study Specialist, primary duties of the CRA include ...
|
|
|
QA Document Control Coordinator
VIRxSYS is a private biotechnology company in Gaithersburg, Maryland which develops gene therapy treatments for serious diseases utilizing its proprietary lentiviral ...
|
|
|
ASSOCIATE DIRECTOR, MECHANICAL ENGINEERING - MEDICAL DEVICE
A public company, our client is a leader in molecular diagnostics with proprietary DNA and RNA tests focused on women's cancers and infectious diseases. R...
|
|
|
Database/Web Programmer
Programmer
Database/Web Programmer
Rockville based contract research organization who works in health and pharmaceutical fields seeks programmer who will ...
|
|
|
Histology Technician
Bold ideas. People who dare to dream big.
We're on a quest to improve the human condition. And we need extraordinary people to be a part of where we're headed -...
|
|
|
Quality Assurance Auditor
Bold ideas. People who dare to dream big.
We're on a quest to improve the human condition. And we need extraordinary people to be a part of where we're headed -...
|
|
|
Research Associate (1059)
Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop and market products that fight serious medical conditions. The C...
|
|
|
Manager/Supervisor of Pharmaceutical GMP Operations
Supernus Pharmaceuticals, Inc. has an immediate opening to hire an experienced management personnel to lead our cGMP Operations department. For more information about S...
|
|
|
Director of Quality Assurance
Acambis is a biotechnology company discovering, developing and manufacturing novel vaccines to prevent and treat infectious diseases. We are based in Cambridge, U...
|
|
|
Sr QA Specialist
UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTECenter for Advanced Research in Biotechnology
Rockville, Maryland
VACANCY ANNOUNCEMENT
Title: S...
|
|
| Related press releases |
Rights issue that rates as a late discovery
For nearly five years now, ICI has been reassuring anyone who wanted to know that its mountainous debts were more than manageable. Never mind that at £2.9bn, they to...
|
|
HIV rates will almost double by 2005
The number of people living with diagnosed HIV is set to rise by almost 50% by 2005, public health officials warned today. The latest UK-wide projections show the number...
|
|
Fed pegs rates after year of cuts
The US Federal Reserve ended its year-long campaign of interest rate cuts last night, keeping borrowing costs unchanged after government figures showed the economy record...
|
|
Rising demand for nannies boosts pay rates
The fast growing demand for daily nannies to look after children whose parents both work has boosted incomes in central London by nearly four times the rate of inflation,...
|
|
Patient death rates to be made public
The patient death rate of every heart surgeon in the country is to be made public within two years, the government announced yesterday in its final response to the Kenned...
|
|
League tables to show surgeon death rates
The first league tables of heart surgeons' death rates were today promised by the government in its latest attempt to create a more patient-centred NHS and make doctors m...
|
|
US fails to respond to rate cuts
The Federal Reserve, America's central bank, dashed hopes of an early recovery in the world's biggest economy when it warned yesterday that despite 11 cuts in interest ra...
|
|
Sir Eddie denies that rates will soon be on way back up
Sir Eddie George, the governor of the Bank of England, last night eased fears of early increases in interest rates to choke off Britain's consumer boom. He said that borr...
|
|
Inflation concern leaves loan rate on hold
Fears that the consumer spending spree on the high streets at Christmas could push up inflation prompted the Bank of England to keep borrowing costs unchanged yesterday, ...
|
|
Bank surprises City by raising rates
The Bank of England today surprised the City by raising rates 0.25% to 4.25% amid concern that the lowest borrowing costs in 37 years have fuelled a spending boom.
The B...
|
|
|
|